W. Zilly - Concepedia

Author

W. Zilly

Leiden University

Also Known As

W Zilly, W. ZILLY, W. Zilly, Walter Zilly

Publications

952

Citations

H-Index

Concepts

All Affiliations

Leiden University University of Würzburg Klinik Rosenberg Medizinische Hochschule Hannover Maastricht University Medical Centre

About

W. Zilly is an author at Leiden University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	482
2	Health Sciences	2	2	68
3	Gastroenterology	2	2	36
4	Allergy	1	1	13
5	Clinical Nutrition	1	1	12

W. Zilly

Publications

845

Citations

H-Index

Page 1

	Year	Citations
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance W. Zilly, D. D. Breimer, Erik A. Richter European Journal of Clinical Pharmacology Drug AnalysisPharmacological StudyRifampicin TreatmentMedicineTolbutamide Clearance	1975	116
Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis R. Joeres, Hartwig Klinker, H. Heusler, Hepatology	1988	89
Pharmacokinetic Interactions with Rifampicin W. Zilly, D. D. Breimer, Erik A. Richter Clinical Pharmacokinetics Pharmacokinetic InteractionsPharmacological StudyPharmacologyPharmacotherapyAntimicrobial Pharmacokinetics	1977	66
Influence of rifampicin on drug metabolism: Differences between hexobarbital and antipyrine D. D. Breimer, W. Zilly, Erik A. Richter Clinical Pharmacology & Therapeutics	1977	61
Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recovery D. D. Breimer, W. Zilly, Erik A. Richter Clinical Pharmacology & Therapeutics Hepatitis BPharmacotherapyHepatic DisordersViral HepatitisHematology	1975	56
Nutrient Malassimilation Following Total Gastrectomy R Brägelmann, U. Armbrecht, D Rosemeyer, Scandinavian Journal of Gastroenterology	1996	54
Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance W. Zilly, D.D. Breimer, Erik A. Richter European Journal of Clinical Pharmacology Increased HexobarbitalHepatologyLiver PhysiologyPharmacologyTolbutamide Clearance	1977	51
Hexobarbital disposition in compensated and decompensated cirrhosis of the liver W. Zilly, D. D. Breimer, Erik A. Richter Clinical Pharmacology & Therapeutics Hepatic DisordersHepatologyHexobarbital DispositionNormal Liver FunctionMedicine	1978	46
Pharmacokinetics and metabolism of theophylline in patients with liver diseases. Staib Ah, D Schuppan, R. Lissner, PubMed 1-Methyl Uric AcidPharmacotherapyPhysiologically-based Pharmacokinetic ModelingHepatotoxicityLiver Diseases	1980	42
Pharmacokinetics of hexobarbital in man after intravenous infusion D.D. Breimer, C. Honhoff, W. Zilly, Journal of Pharmacokinetics and Biopharmaceutics Intravenous InfusionPhysiologically-based Pharmacokinetic ModelingMedicineHematologyPharmacotherapy	1975	42

Page 1